Abstract DNA-DNA crosslinks are the lethal cellular mechanism of bifunctional alkylating agent cytotoxicity. Novobiocin, an inhibitor of DNA topoisomerase II, impairs eukaryotic DNA repair of alkylating agent adducts and may increase the number of adducts and their resultant cytotoxicity in malignant cells. The effect of novobiocin on clonogenic survival and DNA crosslinking due to cisplatin (cDDP) and carmustine (BCNU) was studied. Novobiocin caused synergistic cytotoxicity in Chinese hamster ovary cells exposed to cDDP or BCNU. Novobiocin and cDDP increased the formation of DNA-DNA interstrand crosslinks sixfold greater than cDDP alone. The effect was schedule dependent. Novobiocin and cDDP or BCNU markedly reduced in vivo growth of a murine fibrosarcoma without increased host toxicity. As a modulating agent of cytotoxicity due to DNA-DNA crosslinking, novobiocin may enhance the clinical effectiveness of the alkylating agents in human cancer and offer insight into new therapeutic strategies.
Introduction
The alkylating agents (AA)' are an important class of anti-tumor agents (1) and play a major role in the successful treatment of selected human cancers (2) . The introduction of cis-diamminedichloroplatinum(II) (cDDP) a nonclassical alkylating agent has further extended the efficacy of AA in the clinic (3) .
The clinically effective AA are bifunctional; that is, they have the capacity to form two covalent linkages. Although they may combine with many nucleophilic sites within the cell, there is compelling evidence that their cytotoxicity is the result of DNA monoadduct formation followed by inter-or intrastrand crosslinks in DNA (4-7). The kinetics of monoadduct and crosslink formation, the nature and sites of binding to nucleic acid bases, and the efficacy and kinetics of DNA repair vary among the AA Address reprint requests to Dr. Eder, Beth Israel Hospital, 330 Brookline Avenue, DA-601, Boston, MA 02215. (4-7). The net quantity of crosslinks formed is a function ofthe extent of initial monoadduct formation and their subsequent progression to DNA-DNA crosslinks. An 60-alkylguanine-DNA alkyl transferase has been demonstrated to remove nitrosoureainduced monoadducts and thereby impede crosslink formation (8) . DNA repair mechanisms are believed to be responsible for DNA-DNA crosslink removal (9) . After damage by alkylating agents, enhanced sensitivity of cells from individuals with selective deficiencies of DNA repair activity is observed (10) . Furthermore, the disappearance kinetics of DNA-DNA crosslinks after exposure of neoplastic cells to bifunctional alkylating agents are consistent with their removal by a repair process (9) . The relationship of the crosslink index to cytotoxicity raises the possibility that the effectiveness ofalkylating agents may be enhanced by either increasing the number ofalkylation adducts in cellular DNA or decreasing their repair (1 1).
To investigate this question, we have studied the effects of novobiocin (N), an inhibitor ofeukaryotic DNA replication and repair (12) , on the formation of DNA-DNA crosslinks and cytotoxicity of the bifunctional AA cDDP and 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU). N inhibits DNA repair synthesis after damage by ultraviolet light irradiation or N-methyl-N-nitro-N-nitrosoguanidine (MNNG) (12) . The DNA repair sensitive target of N is not a DNA polymerase but DNA topoisomerase II (Top II), an enzyme important in DNA supercoiling and catenation/decatenation, which has an essential role in eukaryotic DNA replication, RNA transcription, and mitosis (13) (14) (15) .
In the present study, the addition of N to either cDDP or BCNU produced synergistic cytotoxicity in cultured Chinese hamster ovary (CHO) cells with a marked increase in DNA-DNA crosslinks. Similar cytotoxicity was observed in two independent in vivo animal tumor model systems, the FSaII murine fibrosarcoma and the murine L 12 10 leukemia.
Methods
Clonogenic survival studies. CHO cells were grown in Ham's F12 media with 10% fetal bovine serum (FBS), penicillin (250 U/ml), and streptomycin (250 ,ug/ml) at 37°C and 5% CO2. 102 or 103 cells from subconfluent cultures were plated on 60-mm tissue culture dishes (Falcon Labware, Oxnard, CA) and exposed to the appropriate drugs 12-18 h after plating (cell cycle time 1 1-14 h ( 16, 17) , isobolograms were generated for the special case in which the dose of one agent is held constant. This method produces envelopes of additive effect for different levels of the variable agent. This is conceptually identical to generating a series of isobolograms and replotting the results at a constant dose of one agent on a log effect by dose of the second agent coordinate system to give a complete dose-response curve. The envelopes of additivity shown in the figures were generated from a series of iso-effect curves derived from the complete dose-response curves for each agent alone. Overall, combinations that produce an effect that is within the boundaries of the shaded envelope are considered additive. Those displaced to the left are supra-additive while those displaced to the right are sub-additive ( 18, 19) .
To facilitate these analyses a flexible interactive computer program in BASIC was written for the Apple II+ microcomputer (Cupertino, CA). The program first derives the best fitting dose-response curves using dose or log dose, and effect, log effect, probit percent effect, of logit percent effect relations. Radioactivity remaining unfiltered was determined by treating filters with 0.4 ml of 1 N HCl at 650C for 1 h followed by 2.5 ml of 0.4 N NaOH at room temperature for I h, and then adding 12 ml of Aquasol.
As an internal standard, 3H-labeled CHO cells irradiated with 150 rad at 0C were used. To assay for either DNA strand breaks or crosslinks, the cells were eluted both directly and after exposure to 600 rad to 0C. After x-ray exposure the cells were kept at 0°C to avoid repair of DNA breaks. X-irradiation introduces a controlled number of strand breaks in the DNA, and crosslinking is manifested by an inhibition ofthe effect ofthe x-ray dose on the elution ofkinetics. The experiments distinguished DNA protein links from DNA interstrand crosslinks by using proteinase K (0.5 mg/ml) in the lysis solution. The crosslinking factor (CLF) was calculated as CLF = [log (irradiated control/control)]/[log (irradiated drug/control)].
Antitumor activity in vivo. Antitumor activity of N in combination with cDDP or BCNU was assessed in two transplantable mouse tumors: dependent. Maximal cytotoxicity was observed when cells were treated with N from 1 h prior to the addition ofeither alkylating agent through 24 h following exposure (Fig. 3) . IfN was removed prior to the addition of the alkylating agent, the reduction in clonogenic survival was diminished and synergistic cytotoxicity was not observed if the cells were exposed to N after treatment with either of the alkylating agents. Alkaline elution studies. Since DNA crosslinks correlate with cytotoxicity of BCNU and cDDP, the biochemical consequences ofthe interaction ofN and AA was investigated using the alkaline elution technique. Detailed studies were performed with cDDP because ofthe ease with which it is measured in alkaline elution studies. At 1 h the CLF for N and cDDP was 30% higher than for cDDP alone (Fig. 4) . N did not result in formation ofDNA-DNA crosslinks alone. At 12 h, when DNA-DNA crosslinks are expected to be maximal, the difference between N treated 1.07 and untreated cells was sixfold (21.2 vs. 3.6 for N/cDDP vs. cDDP alone). The CLF for cDDP increased 35% over 12 h, whereas the combination was associated with a rise of 533% during the same time. At 24 h the CLF was 37% of maximal for cDDP alone, and 56% for N/cDDP, indicating that the most striking differences were observed during the period ofcrosslink formation, rather than their disappearance. Studies that employed N before and during cDDP exposure, but in which N was removed during the postincubation period failed to show an increase in DNA crosslink formation beyond that which was observed at 1 h. In vivo studies. The effect of the addition of N to treatment with cDDP or BCNU was assessed in two murine tumor systems. The L12 10 leukemia is a rapidly growing ascites tumor. N increased the life span of mice bearing the L12 10 leukemia when added to treatment with either cDDP or BCNU (Table I) . There was an additional 1.3-fold increase in life span in mice treated with N and cDDP and additional 1.2-fold increase in life span in animals treated with N and BCNU (P value not significant). N alone had a small effect on this tumor; therefore, it is possible that the increases in life span seen with the drug combinations may represent an additive response to each agent. The FSaII fibrosarcoma is a solid tumor growing subcutaneously in the flank. N at the same total dose used in the leukemia experiment had very little effect on the growth of this tumor, however, the combination of N with cDDP produced a 2.8-fold increase in tumor growth delay compared to cDDP alone (P < 0.0005) and the combination of N with BCNU produced a 9.0-fold increase in tumor growth delay compared with BCNU alone (P < 0.001).
Discussion
The biochemical basis for N synergistic effects is not understood. The compound is known to inhibit bacterial DNA gyrase, a Top II that relaxes and supercoils double-stranded DNA (21) . N has been shown to inhibit eukaryotic Top II in vitro (22) , and its effects are ATP dependent (21) . An inhibition (23) . The latter effect is associated with inhibition of transcription in Xenopus (24) . N will inhibit the eukaryotic DNA polymerase alpha (25) , bacterial DNA polymerase and DNA ligase (26) . In addition to interfering with semiconservative replication, N has been demonstrated to inhibit DNA repair synthesis following damage with ultraviolet light or MNNG (12) . By reversible breakage and union of two DNA strands and the passage ofdouble-stranded DNA through the enzyme bridged gap, Top II can alter the conformation of constrained nuclear DNA (27) . As such, it is important in a number of essential cellular functions such as mitosis, DNA repair, DNA replication, and possibly transcription. Furthermore, Top II has been identified as the target of several antineoplastic agents (28) (29) (30) . These agents, such as adriamycin, the epipodophyllotoxins and m-AMSA (4'-[9-acridinyl amino]methanesulfon-m-anisidide), stabilize the Top II-DNA cleaved strand complex that results in DNA strand scission (28) (29) (30) .
N exerts a far more potent enhancement effect on alkylating agents than etoposide (Teicher, B. A., unpublished data) and is minimally toxic by comparison. The mechanism underlying this effect may be multifactorial, involving Top II inhibition and or other enzyme systems. Considering the magnitude of the N associated enhancement observed in vitro and in vivo, a complete understanding of this agent's effects may lead to the advent of novel treatment strategies to be evaluated in the clinic.
